Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#16 most reported symptom for this vaccine
Injection site pain has been reported 8 times in association with Mumps (Mumpsvax II) vaccination in VAERS. This represents 4.7% of all 171 reports for this vaccine.
Among these reports, 2 mentioned death (25.00%) and 2 involved hospitalization (25.0%).
Injection site pain is the #16 most frequently reported symptom for Mumps (Mumpsvax II) out of 66 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 8 reports of Injection site pain after Mumps (Mumpsvax II) vaccination may seem alarming, but context is critical.
The 25.00% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.